Clinical trial
Arginine Therapy in Sickle Cell Disease-VOC Clinical Trial
NCT01796678 is registered in ClinicalTrials.gov with UCSF Benioff Children's Hospital Oakland as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Arginine Therapy in Sickle Cell Disease-VOC Clinical Trial
- Lead sponsor
- UCSF Benioff Children's Hospital Oakland
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- September 30, 2000
- Completion date
- June 30, 2007
- Enrollment
- 56 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
vaso-occlusive pain episodes